We caught ICLD coming off of its bottom, and tagged the stock in our report from two Thursday's ago on the 2nd. Subsequent to that, we would witness a low of .0157 in the stock, and since then it has been one big bullish run that led to an impressive new high on Friday.
We've stayed with it each step of the way as it rose from that .0157 low to Friday's top mark of .0465. That works out to a fantastic move of 196% which occurred over a period of just seven trading sessions.
The sheer amount of activity in the stock on Friday, with more than $6M worth of ICLD shares changing hands, coupled with the strong close has us very interested to track its movements as it leaves the starting gate this morning.
We also prepared a video presentation of the ICLD Chart and its recent movements that you can view by clicking the graphic below:
Catabasis Pharmaceuticals, Inc. CATB
Speaking of catching plays coming off of their bottoms, we signaled CATB in Friday's premarket report, noting the monster gap on its chart to the upside.
We highlighted this one just in the nick of time, as the move it made during Friday's session ultimately provided for the filling of around three quarters of that gap. CATB ran from a low of 1.58 and went on to hit a high of 2.76, for a very respectable intraday pop of 75%
In terms of what we want to see moving forward, we'll be looking for CATB to maintain a level of support each day higher than the previous session.
Side Note: These two winners (ICLD, CATB) from Friday's report also happened to turn in the two top-gaining performances for the entire NASDAQ exchange for Friday's session!
Aviragen Therapuetics, Inc. AVIR
We also want to issue a quick alert on yet another potential bottom play that appears to be perfectly primed for a rebound. As you can see plainly on the chart snapshot below, there is a sizable gap to fill to the upside, and our favorite indicators are screaming 'bullish' at this point.
The chances of seeing a rebound out of AVIR sooner rather than later seem quite good as we kick off another trading week.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Our disclaimer is to be read and fully agreed to before using our site, or joining our email list. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions, however any that may occur will be corrected as needed. BHS and its affiliates are not registered or licensed investment advisers, nor broker dealers. BHS cautions that the investments in companies profiled are commonly considered to be extremely high risk and use of any information provided is at the investor's sole risk.